TELA Bio, Inc. (TELA) Financials
TELA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 87.3 million | 56.8 million |
2023-06-30 | 94.4 million | 54.4 million |
2023-03-31 | 58.8 million | 55.6 million |
2022-12-31 | 67.9 million | 53.6 million |
TELA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.1 million | 1.4 million |
2023-06-30 | -11.4 million | 1.3 million |
2023-03-31 | -11.7 million | 1.1 million |
2022-12-31 | -12.0 million | 1.0 million |
TELA Net Income
No data available :(
TELA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 58.2 million | - | 345000 |
2023-06-30 | 65.3 million | 40.2 million | 343000 |
2023-03-31 | 30.1 million | 40.1 million | 342000 |
2022-12-31 | 42.0 million | 39.9 million | 340000 |
TELA Shares Outstanding
TELA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 134000 | 2.4 million | 3.7 million | 14.5 million |
2023-06-30 | 157000 | 2.5 million | 3.5 million | 14.6 million |
2023-03-31 | 115000 | 2.1 million | 3.6 million | 13.5 million |
2022-12-31 | 1.0 million | 2.7 million | 3.2 million | 11.6 million |
TELA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 15.1 million | 4.7 million |
2023-06-30 | 14.5 million | 4.3 million |
2023-03-31 | 11.9 million | 4.0 million |
2022-12-31 | 11.6 million | 3.4 million |
TELA
Price: $4.72
52 week price:
Earnings Per Share: -2.04 USD
P/E Ratio: -3.52
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 32300
Market Capitalization: 131.1 million